Tower Research Capital LLC (Trc) Bio Atla, Inc. Transaction History

Tower Research Capital LLC (Trc)

$4.87 Billion
Q4 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Bio Atla, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,939 shares of BCAB stock, worth $1,959. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,939

Previous 5,135 15.66%

Holding current value

$1,959

Previous $9,000 66.67%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$0.59 - $2.37 $474 - $1,905	804 Added 15.66%	5,939 $3,000
Q3 2024 Nov 14, 2024	SELL	$1.17 - $2.05 $14,901 - $26,108	-12,736 Reduced 71.27%	5,135 $9,000
Q2 2024 Aug 13, 2024	BUY	$1.37 - $3.92 $22,426 - $64,170	16,370 Added 1090.61%	17,871 $24,000
Q1 2024 May 15, 2024	SELL	$1.88 - $3.46 $6,425 - $11,826	-3,418 Reduced 69.49%	1,501 $5,000
Q4 2023 Feb 13, 2024	SELL	$1.27 - $3.18 $3,550 - $8,891	-2,796 Reduced 36.24%	4,919 $12,000
Q3 2023 Nov 14, 2023	BUY	$1.7 - $3.07 $5,210 - $9,409	3,065 Added 65.91%	7,715 $13,000
Q2 2023 Aug 14, 2023	SELL	$2.83 - $3.87 $18,805 - $25,716	-6,645 Reduced 58.83%	4,650 $13,000
Q1 2023 May 09, 2023	BUY	$2.3 - $8.25 $10,835 - $38,865	4,711 Added 71.55%	11,295 $30,000
Q4 2022 Feb 10, 2023	BUY	$6.29 - $11.01 $28,801 - $50,414	4,579 Added 228.38%	6,584 $54,000
Q3 2022 Nov 10, 2022	SELL	$2.94 - $11.87 $9,081 - $36,666	-3,089 Reduced 60.64%	2,005 $15,000
Q2 2022 Aug 15, 2022	SELL	$2.13 - $5.38 $5,222 - $13,191	-2,452 Reduced 32.49%	5,094 $14,000
Q1 2022 May 12, 2022	BUY	$4.38 - $18.78 $14,248 - $61,091	3,253 Added 75.77%	7,546 $37,000
Q4 2021 Feb 14, 2022	BUY	$19.0 - $30.95 $28,253 - $46,022	1,487 Added 52.99%	4,293 $84,000
Q3 2021 Nov 15, 2021	BUY	$29.44 - $43.74 $68,477 - $101,739	2,326 Added 484.58%	2,806 $83,000
Q2 2021 Aug 16, 2021	SELL	$38.07 - $56.17 $38,564 - $56,900	-1,013 Reduced 67.85%	480 $20,000
Q1 2021 May 17, 2021	BUY	$32.41 - $70.91 $48,388 - $105,868	1,493 New	1,493 $76,000

Others Institutions Holding BCAB

# of Institutions

Shares Held

23.4M

Call Options Held

30.8K

Put Options Held

57K

View Full List

About BioAtla, Inc.

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $12M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

More about BCAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Bio Atla, Inc. Transaction History